EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Pathobiochemistry of Vitamin B12 Deficiency: Improving Our Understanding by Exploring Novel Mechanisms with a Focus on Diabetic Neuropathy

Erwin Schleicher, Triantafyllos Didangelos iD, Evangelia Kotzakioulafi, Alexander Cegan, Andreas Peter, Konstantinos Kantartzis iD

Nutrients · 01.06.2023 · 15 (11) · 2597

DOI: 10.3390/nu15112597 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 01.06.2023. Verfasst von Erwin Schleicher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital of Tübingen, 72076 Tübinge…. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Vitamin B 12 Deficiency, Diabetes Mellitus. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin B12 (B12) is an essential cofactor of two important biochemical pathways, the degradation of methylmalonic acid and the synthesis of methionine from homocysteine. Methionine is an important donor of methyl groups for numerous biochemical reactions, including DNA synthesis and gene regulation. Besides hematological abnormalities (megaloblastic anemia or even pancytopenia), a deficiency in B12 may cause neurological symptoms, including symptoms resembling diabetic neuropathy. Although extensively studied, the underlining molecular mechanism for the development of diabetic peripheral neuropathy (DPN) is still unclear. Most studies have found a contribution of oxidative stress in the development of DPN. Detailed immunohistochemical investigations in sural nerve biopsies obtained from diabetic patients with DPN point to an activation of inflammatory pathways induced via elevated advanced glycation end products (AGE), ultimately resulting in increased oxidative stress. Similar results have been found in patients with B12 deficiency, indicating that the observed neural changes in patients with DPN might be caused by cellular B12 deficiency. Since novel results show that B12 exerts intrinsic antioxidative activity in vitro and in vivo, B12 may act as an intracellular, particularly as an intramitochondrial, antioxidant, independent from its classical, well-known cofactor function. These novel findings may provide a rationale for the use of B12 for the treatment of DPN, even in subclinical early states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesVitamin B 12 DeficiencyDiabetes MellitusHumansVitamin B 12AntioxidantsMethionineVitamins

Stichwörter der Autor:innen

Vitamin B12cobalamindiabeteshomocysteinelaboratory biomarkermethylmalonic acidoxidative stressperipheral neuropathyreactive oxygen speciesredox

Substanzen

Vitamin B 12AntioxidantsMethionineVitamins

Autor:innen und Institutionen

  • Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital of Tübingen, 72076 Tübingen, Germany.
  • Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich, German Center for Diabetes Research (DZD), 72076 Tübingen, Germany.
  • German Center for Diabetes Research (DZD e.V.), 85764 Neuherberg, Germany.
  • Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Medical School, "AHEPA" Hospital, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece.
  • Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, 53210 Pardubice, Czech Republic.
  • Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University of Tübingen, 72076 Tübingen, Germany.

ORCID-Profile: Triantafyllos Didangelos, Konstantinos Kantartzis

Zitieren

APA

Schleicher, E., Didangelos, T., Kotzakioulafi, E., Cegan, A., Peter, A., & Kantartzis, K. (2023). Clinical Pathobiochemistry of Vitamin B12 Deficiency: Improving Our Understanding by Exploring Novel Mechanisms with a Focus on Diabetic Neuropathy. Nutrients, 15(11), 2597. https://doi.org/10.3390/nu15112597

Vancouver

Schleicher E, Didangelos T, Kotzakioulafi E, Cegan A, Peter A, Kantartzis K. Clinical Pathobiochemistry of Vitamin B12 Deficiency: Improving Our Understanding by Exploring Novel Mechanisms with a Focus on Diabetic Neuropathy. Nutrients. 2023;15(11):2597. doi:10.3390/nu15112597

BibTeX
@article{Schleicher2023,
  author = {Schleicher, Erwin and Didangelos, Triantafyllos and Kotzakioulafi, Evangelia and Cegan, Alexander and Peter, Andreas and Kantartzis, Konstantinos},
  title = {Clinical Pathobiochemistry of Vitamin B12 Deficiency: Improving Our Understanding by Exploring Novel Mechanisms with a Focus on Diabetic Neuropathy},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {11},
  pages = {2597},
  doi = {10.3390/nu15112597}
}
Kostenlos starten →